Effect of Tadalafil on Seizure Threshold and Activity of Antiepileptic Drugs in Three Acute Seizure Tests in Mice

Overview

Journal Neurotox Res

Publisher Springer

Specialty Neurology

Date 2018 Feb 11

PMID 29427285

Citations 10

Authors

Katarzyna Socala

Dorota Nieoczym

Mateusz Pierog

Elzbieta Wyska

Malgorzata Szafarz

Urszula Doboszewska

Piotr Wlaz

Affiliations

Soon will be listed here.

Abstract

Tadalafil, a selective phosphodiesterase type 5 inhibitor, is a long-acting oral agent for the treatment of erectile dysfunction of multiple etiologies. Although generalized tonic-clonic seizures were reported in a healthy man after taking tadalafil, the influence of tadalafil on seizure susceptibility has not been studied so far. Therefore, the aim of the present study was to investigate the effect of tadalafil on seizure threshold as well as on the activity of some first- and second-generation antiepileptic drugs in three acute seizure tests in mice. The obtained results showed that tadalafil, at the highest dose tested (20 mg/kg), significantly decreased the threshold for the first myoclonic twitch in the intravenous pentylenetetrazole (i.v. PTZ) seizure test. It did not affect the threshold for generalized clonic seizure and forelimb tonus in the i.v. PTZ, for tonic hindlimb extension in the maximal electroshock seizure threshold test, and for psychomotor seizure in the 6-Hz-induced seizure threshold test. Tadalafil did not alter the anticonvulsant activity of any of the studied antiepileptic drugs in electrically induced seizure tests. Interestingly, tadalafil potentiated the anticonvulsant activity of clonazepam and decreased the anticonvulsant activity of oxcarbazepine in the i.v. PTZ test. These interactions were pharmacodynamic in nature, as tadalafil did not alter clonazepam and oxcarbazepine concentrations both in serum and brain tissue. Furthermore, neither tadalafil alone nor its combinations with the studied antiepileptic drugs produced any significant impairment of motor coordination (assessed in the chimney test), muscular strength (investigated in the grip-strength test), and long-term memory (assessed in the passive avoidance task). In conclusion, tadalafil may increase the risk of myoclonic seizure and decrease the anticonvulsant efficacy of oxcarbazepine. Further studies are warranted to evaluate the safety of tadalafil usage in patients with epilepsy.

Citing Articles

NLRP3 Inflammasome Inhibition After Pilocarpine-Induced Status Epilepticus Attenuates Chronic Inflammation in Epileptic Mice.

Wang L, Wang K, Chen Y, Zhang X, Xu W, Dong Z J Inflamm Res. 2024; 17:6143-6158.

PMID: 39262652 PMC: 11389722. DOI: 10.2147/JIR.S469451.

Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates.

Jakubiec M, Abram M, Zagaja M, Socala K, Panic V, Latacz G ACS Chem Neurosci. 2024; 15(17):3228-3256.

PMID: 39166702 PMC: 11378297. DOI: 10.1021/acschemneuro.4c00438.

Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization.

Jakubiec M, Abram M, Zagaja M, Andres-Mach M, Szala-Rycaj J, Latacz G ACS Chem Neurosci. 2024; 15(11):2198-2222.

PMID: 38741575 PMC: 11157491. DOI: 10.1021/acschemneuro.4c00013.

Unmasking hidden risks: The surprising link between PDE5 inhibitors and seizure susceptibility.

Silva A, Nascimento C, Azevedo J, Vieira L, Hamoy A, da Silva Tiago A PLoS One. 2023; 18(11):e0294754.

PMID: 38033148 PMC: 10688920. DOI: 10.1371/journal.pone.0294754.

TC-G 1008 facilitates epileptogenesis by acting selectively at the GPR39 receptor but non-selectively activates CREB in the hippocampus of pentylenetetrazole-kindled mice.

Doboszewska U, Socala K, Pierog M, Nieoczym D, Sawicki J, Szafarz M Cell Mol Life Sci. 2023; 80(5):133.

PMID: 37185787 PMC: 10130118. DOI: 10.1007/s00018-023-04766-z.

References

Nieoczym D, Socala K, Luszczki J, Czuczwar S, Wlaz P . Sildenafil influences the anticonvulsant activity of vigabatrin and gabapentin in the timed pentylenetetrazole infusion test in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 39(1):129-35. DOI: 10.1016/j.pnpbp.2012.05.020. View

Harden C . Treatment of sexual disorders in people with epilepsy. Epilepsy Behav. 2003; 3(5S):38-41. DOI: 10.1016/s1525-5069(02)00504-2. View

Ferrendelli J, Blank A, Gross R . Relationships between seizure activity and cyclic nucleotide levels in brain. Brain Res. 1980; 200(1):93-103. DOI: 10.1016/0006-8993(80)91097-5. View

Matsumoto R, Truong D, Nguyen K, Dang A, Hoang T, Vo P . Involvement of GABA(A) receptors in myoclonus. Mov Disord. 2000; 15 Suppl 1:47-52. DOI: 10.1002/mds.870150709. View

Loscher W . Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011; 20(5):359-68. DOI: 10.1016/j.seizure.2011.01.003. View

Garcia-Barroso C, Ricobaraza A, Pascual-Lucas M, Unceta N, Rico A, Goicolea M . Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD. Neuropharmacology. 2012; 64:114-23. DOI: 10.1016/j.neuropharm.2012.06.052. View

Mandhane S, Aavula K, Rajamannar T . Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure. 2007; 16(7):636-44. DOI: 10.1016/j.seizure.2007.05.005. View

Matos G, Scorza F, Cavalheiro E, Tufik S, Andersen M . PDEI-5 for erectile dysfunction: a potential role in seizure susceptibility. J Sex Med. 2012; 9(8):2111-21. DOI: 10.1111/j.1743-6109.2012.02780.x. View

Ferraro G, Sardo P . Nitric oxide and brain hyperexcitability. In Vivo. 2004; 18(3):357-66. View

10.

Huang S, Lie J . Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction. P T. 2013; 38(7):407-19. PMC: 3776492. View

11.

McKinlay J . The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000; 12 Suppl 4:S6-S11. DOI: 10.1038/sj.ijir.3900567. View

12.

White H, Scholl E, Klein B, Flynn S, Pruess T, Green B . Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models. Neurotherapeutics. 2009; 6(2):372-80. PMC: 4402707. DOI: 10.1016/j.nurt.2009.01.001. View

13.

Nieoczym D, Socala K, Jedziniak P, Olejnik M, Wlaz P . Effect of sildenafil, a selective phosphodiesterase 5 inhibitor, on the anticonvulsant action of some antiepileptic drugs in the mouse 6-Hz psychomotor seizure model. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 47:104-10. DOI: 10.1016/j.pnpbp.2013.08.009. View

14.

Giordano C, Costa A, Lucchi C, Leo G, Brunel L, Fehrentz J . Progressive Seizure Aggravation in the Repeated 6-Hz Corneal Stimulation Model Is Accompanied by Marked Increase in Hippocampal p-ERK1/2 Immunoreactivity in Neurons. Front Cell Neurosci. 2016; 10:281. PMC: 5159434. DOI: 10.3389/fncel.2016.00281. View

15.

Coward R, Carson C . Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manag. 2009; 4(6):1315-30. PMC: 2643112. DOI: 10.2147/tcrm.s3336. View

16.

Vieira F, Ronsoni M, Hohl A, Claudino L, Diaz A, Schwarzbold M . How predictable is the erectile function of patients with epilepsy?. Epilepsy Behav. 2015; 47:61-5. DOI: 10.1016/j.yebeh.2015.04.068. View

17.

Wyllie M . The underlying pathophysiology and causes of erectile dysfunction. Clin Cornerstone. 2005; 7(1):19-27. DOI: 10.1016/s1098-3597(05)80045-6. View

18.

Lucchi C, Costa A, Giordano C, Curia G, Piat M, Leo G . Involvement of PPARγ in the Anticonvulsant Activity of EP-80317, a Ghrelin Receptor Antagonist. Front Pharmacol. 2017; 8:676. PMC: 5614981. DOI: 10.3389/fphar.2017.00676. View

19.

Peixoto C, Nunes A, Garcia-Osta A . Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition. Mediators Inflamm. 2016; 2015:940207. PMC: 4681825. DOI: 10.1155/2015/940207. View

20.

Nieoczym D, Socala K, Rundfeldt C, Wlaz P . Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in rats. Pharmacol Rep. 2010; 62(2):383-91. DOI: 10.1016/s1734-1140(10)70278-4. View